Shanghai INT Medical's Profit Inches Up in 2025; Shares Climb 6%

MT Newswires Live
03/30

Shanghai INT Medical Instruments (HKG:1501) recorded a rise in attributable profit in 2025 to 218.8 million yuan from 191.9 million yuan a year prior, according to a March 27 Hong Kong bourse filing.

Shares of the medical device maker were up nearly 6% in Monday afternoon trading.

Earnings per share rose to 1.26 yuan from 1.10 yuan in the previous fiscal year.

Revenue increased 25% to 1.07 billion yuan from 852 million yuan in the year-ago period, mainly due to a higher number of new customers.

The company recommended a final dividend of 0.23 yuan per share for the year, payable on or around June 30 to shareholders of record on June 10.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10